Literature DB >> 2523562

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Q L Choo1, G Kuo, A J Weiner, L R Overby, D W Bradley, M Houghton.   

Abstract

A random-primed complementary DNA library was constructed from plasma containing the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH. A complementary DNA clone was isolated that was shown to encode an antigen associated specifically with NANBH infections. This clone is not derived from host DNA but from an RNA molecule present in NANBH infections that consists of at least 10,000 nucleotides and that is positive-stranded with respect to the encoded NANBH antigen. These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae. This molecular approach should be of great value in the isolation and characterization of other unidentified infectious agents.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523562     DOI: 10.1126/science.2523562

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  1505 in total

Review 1.  Hepatitis C in childhood.

Authors:  F Bortolotti
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

Review 2.  Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management.

Authors:  V P Choudhry; S K Acharya
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

Review 3.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Mutations that affect dimer formation and helicase activity of the hepatitis C virus helicase.

Authors:  Y L Khu; E Koh; S P Lim; Y H Tan; S Brenner; S G Lim; W J Hong; P Y Goh
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  A computer model of the spread of hepatitis C virus among injecting drug users.

Authors:  D Mather; N Crofts
Journal:  Eur J Epidemiol       Date:  1999-01       Impact factor: 8.082

6.  A study on the role of the family and other risk factors in HCV transmission.

Authors:  S Brusaferro; F Barbone; P Andrian; G Brianti; L Ciccone; A Furlan; D Gnesutta; S Stel; E Zamparo; P Toniutto; P Ferroni; V Gasparini
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

7.  Natural variation in translational activities of the 5' nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long-range RNA-RNA interaction outside of the internal ribosomal entry site.

Authors:  M Honda; R Rijnbrand; G Abell; D Kim; S M Lemon
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 8.  Current status of hepatitis C in Canada.

Authors:  S Zou; M Tepper; A Giulivi
Journal:  Can J Public Health       Date:  2000 Jul-Aug

Review 9.  Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics.

Authors:  N Usman; L M Blatt
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

10.  A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans.

Authors:  S M Lemon; H Lerat; S A Weinman; M Honda
Journal:  Trans Am Clin Climatol Assoc       Date:  2000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.